Hostname: page-component-848d4c4894-sjtt6 Total loading time: 0 Render date: 2024-06-19T15:21:22.516Z Has data issue: false hasContentIssue false

Predictive Models of Metabolic Syndrome for Patients with Schizophrenic or Bipolar Disorders

Published online by Cambridge University Press:  16 April 2020

P. Garcia-Portilla
Affiliation:
Psychiatry, University of Oviedo, Oviedo, Spain CIBERSAM, University of Oviedo, Oviedo, Spain
S. Santamarina
Affiliation:
Mental Health Services, SESPA, Langreso, Oviedo, Spain
P.A. Saiz
Affiliation:
Psychiatry, University of Oviedo, Oviedo, Spain CIBERSAM, University of Oviedo, Oviedo, Spain
F. Sánchez
Affiliation:
Tecniproject, Avilés, Oviedo, Spain
E. Diaz-Mesa
Affiliation:
CIBERSAM, University of Oviedo, Oviedo, Spain
C. Iglesias
Affiliation:
Mental Health Services, SESPA, Oviedo, Spain
J. Bobes
Affiliation:
Psychiatry, University of Oviedo, Oviedo, Spain CIBERSAM, University of Oviedo, Oviedo, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Metabolic syndrome is a frequent, severe, undiagnosed physical comorbidity in patients with severe mental disorders.

Aim

To develop a predictive model of metabolic syndrome for patients with schizophrenic or bipolar disorders, useful for both clinical practice and research.

Methods

Naturalistic, one-year follow-up study conducted in Asturias, Spain. A total of 172 patients with schizophrenic (Sch-P) or bipolar (BD-P) disorders (ICD-10 criteria), under maintenance treatment, who gave written informed consent were included. Metabolic syndrome was defined according to the modified NCEP ATP-III criteria. Multivariate Adaptive Regression Splines (MARS), Genetic Algorithms (GA), and Support Vector Machine (SVM) analysis were performed.

Results

Starting from a large set of demographic and clinical variables, and by means of intermediate MARS and GA models, an SVM model able to classify if a patient with schizophrenia or bipolar disorder suffers from metabolic syndrome with an accuracy of 98.68% (sensitivity 100%, specifity 94.4%) was obtained. The final model only needs 6 variables: Sch-P:

  1. (1) Low HDL-cholesterol,

  2. (2) Fasting glucose level,

  3. (3) Family history of obesity,

  4. (4) Triglyceride level,

  5. (5) Family history of dyslipidemia, and

  6. (6) Use of antidepressants; BD-P: (1), (2), (3),

  7. (7) Use of lipid-lowering medication,

  8. (8) Use of antipsychotics, and

  9. (9) Use of mood stabilizers.

Conclusion

We developed a simple and easy to use predictive model to identify metabolic syndrome in patients with schizophrenic or bipolar disorders.

Type
P03-222
Copyright
Copyright © European Psychiatric Association 2011
Submit a response

Comments

No Comments have been published for this article.